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Robin E. Williamson1mtDNA and the Peopling Of the Americas
Fagundes et al., 583
Although it is generally accepted that the Americas were the
last continents to which Homo sapiens were introduced, the
timing and location of this peopling are contended. Early
mtDNA haplogroup data from Native Americans has been
in support of a singlemigration fromAsia, but other evidence
haspointed tomultiple latermigrations.Additionally, there is
disagreement about the size of the founding group that peo-
pled the Americas and whether it was subject to a strong or
moderate bottleneck. Earlier studies of Native Americans
have focused on data from only the control region of the
mtDNA. Because it has been found that such sequences can
be limited and unreliable, Fagundes et al. analyze the com-
plete mtDNA coding sequence of Native Americans from all
majorhaplogroups.Their analyses support a single-migration
scenario with a moderate bottleneck followed by expansion.
Scientific Basis Of Genomic Profiles
Janssens et al., 593
One of the reported goals of identifying associations be-
tween genetic alleles and complex disease is that a personal-
ized assessment of risk could result from testing which var-
iant a person possesses at those loci. Companies are hoping
to beneﬁt from data generated from genetic association
studies by offering such tests to the public. There is some
concern that, because the odds ratios of identiﬁed risk fac-
tors are so low, such analyses can be misleading and even
harmful. Additionally, many reported associations may
not be real or may not have an equal effect in all popula-
tions. Replication andmeta-analyses are required to ensure
that the associations between variants and disease risk are
real. Janssens et al. assess the scientiﬁc basis for the ge-
netic-variant testing that is currently commercially avail-
able. They look at seven companies that, combined, offer
tests for 69 different polymorphisms in 56 different genes.
The authors report that many of the tests are not supported
by signiﬁcant associations in meta-analyses.
Analyzing Distantly Related Individuals
Albers et al., 607
Linkage analysis of distantly related affected individuals can
be a powerful strategy for identifying loci involved in com-plex diseases with incomplete penetrance. One difﬁculty in
such studies is that exact determination of the identity-by-
descent sharingprobabilities is intractable in largepedigrees,
and approximatingmethods viaMarkov chainMonte Carlo
sampling can be time-consuming and complex. Addition-
ally, as denser SNP data becomes available for these analyses,
it becomes increasingly important to take linkage disequi-
librium (LD) into account, and most current methods are
unable to allow for correlation between markers. Albers et al.
develop a method that simpliﬁes the approximation of
linkage statistics in large pedigrees with distantly related
affected individuals. The accuracy of the newmethod, as im-
plemented in theprogramALADIN, is evaluatedondata from
small pedigrees for which exact computation is feasible. The
authors also compareALADIN toother approximationmeth-
ods using data from larger pedigrees. ALADIN is found to be
more accurate and efﬁcient than othermethods, particularly
when used on large pedigrees and when accounting for LD.
SCARB2, Epilepsy, and Glomerulosclerosis
Berkovic et al., 673
Action myoclonus-renal failure syndrome (ARMF) is an au-
tosomal-recessive disorder characterized by renal failure
and progressive neurological symptoms. Because the dis-
ease is lethal and has an age of onset at 15–25 yr, there are
not any large pedigrees to study for gene identiﬁcation
based on linkage strategies. Berkovic et al. use homozygos-
ity-mapping techniques in three unrelated affected individ-
uals to identify a candidate disease region on 4q13-q21. Of
the 66 known genes at this locus, approximately half were
known to be expressed in the brain and in the kidney. To
further pare down this list, the authors predict that the
genemutated in ARMFwould be downregulated in affected
tissues. Gene-expression comparison between patient cells
and control cells reveals that SCARB2 expression is de-
creased in ARMF. SCARB2mutations are found in ARMF pa-
tients, as well as in obligate carriers from one of the original
ARMF families. The authors also compare the human phe-
notype with that of mice deﬁcient for Limp2 (the SCARB2
mouse ortholog) and describe similarities and differences.
Epigenomic Profiling In Major Psychosis
Mill et al., 696
Major psychosis is a term used to encompass the con-
ditions of schizophrenia and bipolar disorder. Although1Deputy Editor, AJHG
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a great deal of effort has been expended in the search for
genetic variants that are associated with these disorders,
very few signiﬁcant associations have been identiﬁed.
Certain observations, such as the fact that environmental
effects cannot account for the lack of concordance of dis-
ease in monozygotic twins and parent-of-origin effects,
have led to the prediction that epigenetic factors may be
involved in the development of major psychosis. Because
epigenetic changes can be tissue speciﬁc and can lead
to gene misregulation, they can affect phenotype in a536 The American Journal of Human Genetics 82, 535–536, Marchdynamic manner independent of genetic variants or muta-
tions. Previous studies have analyzed the methylation
status of certain genes thought to be involved in schizo-
phrenia and/or bipolar disorder, but here Mill et al. per-
form a genome-wide scan of epigenetic variation in the
frontal cortex of cases and controls. The authors identify
a number of regions that show signiﬁcant differences in
methylation proﬁle, and they discuss the gene-ontology
categories that are implicated to be involved in the etiol-
ogy of major psychosis.2008
